TY - JOUR
T1 - Metabolomic profiling of lipids and fatty acids
T2 - 3 years postoperative laparoscopic sleeve gastrectomy
AU - Sharma, Charu
AU - Platat, Carine
AU - Gariballa, Salah
AU - Muhairi, Shamma Jauaan Al
AU - Aidaros, Anas Al
AU - Mannaerts, Guido Hein Huib
AU - Afari, Hamouda Salim Al
AU - Yasin, Javed
AU - Al-Dirbashi, Osama Y.
AU - Alkaabi, Juma
N1 - Funding Information:
Funding: This research received no external funding but was supported by the College of Medicine and Health Sciences, UAE University.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/4
Y1 - 2021/4
N2 - Visceral obesity is common in the United Arab Emirates and worldwide. Although laparoscopic sleeve gastrectomy (LSG) leads to effective and sustainable weight loss, its long-term beneficial impact on other risk factors, including blood lipid and fatty acid (FA) profiles, remains unknown. These two profiles were assessed in patients 3 years after undergoing LSG and in LSG candidates (controls). Lipid profiles were measured using the Cobas e411 modular analyzer, and 35 FAs were identified. The age and body mass index were 36.55 ± 8.65 years and 31.49 ± 6.43 kg/m2 in the LSG group and 35.44 ± 9.51 years and 32.29 ± 5.38 kg/m2 in the control group, respectively. The overall lipid profile was more favorable in the LSG group than in the control group. Total saturated, monounsaturated, and polyunsaturated FAs were similar between the groups, but total medium-chain FAs were more abundant in the LSG group. In endogenous FA synthesis, the estimated activity of C16∆9 desaturase and ∆5 desaturase decreased, whereas that of elongase increased in the LSG group compared with that in the control group. The benefits of LSG on blood lipid and FA profiles in patients with 3-year LSG may be limited. Hence, lifestyle interventions combined with a long-term and strict regular follow-up regime may be warranted for patients undergoing LSG.
AB - Visceral obesity is common in the United Arab Emirates and worldwide. Although laparoscopic sleeve gastrectomy (LSG) leads to effective and sustainable weight loss, its long-term beneficial impact on other risk factors, including blood lipid and fatty acid (FA) profiles, remains unknown. These two profiles were assessed in patients 3 years after undergoing LSG and in LSG candidates (controls). Lipid profiles were measured using the Cobas e411 modular analyzer, and 35 FAs were identified. The age and body mass index were 36.55 ± 8.65 years and 31.49 ± 6.43 kg/m2 in the LSG group and 35.44 ± 9.51 years and 32.29 ± 5.38 kg/m2 in the control group, respectively. The overall lipid profile was more favorable in the LSG group than in the control group. Total saturated, monounsaturated, and polyunsaturated FAs were similar between the groups, but total medium-chain FAs were more abundant in the LSG group. In endogenous FA synthesis, the estimated activity of C16∆9 desaturase and ∆5 desaturase decreased, whereas that of elongase increased in the LSG group compared with that in the control group. The benefits of LSG on blood lipid and FA profiles in patients with 3-year LSG may be limited. Hence, lifestyle interventions combined with a long-term and strict regular follow-up regime may be warranted for patients undergoing LSG.
KW - Fatty acids
KW - Laparoscopic sleeve gastrectomy
KW - Lipids
KW - Obesity
UR - http://www.scopus.com/inward/record.url?scp=85104142035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104142035&partnerID=8YFLogxK
U2 - 10.3390/biology10040298
DO - 10.3390/biology10040298
M3 - Article
AN - SCOPUS:85104142035
SN - 2079-7737
VL - 10
JO - Biology
JF - Biology
IS - 4
M1 - 298
ER -